Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Regional Differences: US vs. UK & Europe Biotech
Jess asks about geographic advantages; Lucio compares deal flow, capital availability, and growth ecosystems across the US, UK, and Europe.
Transcript
Play full episode
